In HNSCC, we further observed higher IL34 levels in HPV+ HNSCC than in HPV‐ HNSCC (Figure 1f), aligning with previous findings of increased immune activity in HPV+ HNSCC.24 This evidence concerns the gene IL34 and head and neck squamous cell carcinoma.